AVBP - CIK 0001868279
ArriVent BioPharma, Inc. has filed 144 documents with the SEC between 2021 and 2026. The most frequent type is insider trade (26 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Major company event | 8-K | 2026-05-11 | 2026-05-11 |
| Prospectus supplement | 424B5 | 2026-05-11 | - |
| Quarterly report | 10-Q | 2026-05-11 | 2026-03-31 |
| Major company event | 8-K | 2026-05-11 | 2026-05-11 |
| SCHEDULE 13G/A | - | 2026-05-06 | - |
| Annual report to shareholders | ARS | 2026-04-28 | 2025-12-31 |
| Proxy materials | DEFA14A | 2026-04-28 | - |
| Proxy statement | DEF 14A | 2026-04-28 | 2026-06-18 |
| Major company event | 8-K | 2026-03-17 | 2026-03-17 |
| Employee stock plan | S-8 | 2026-03-05 | - |
| Annual report | 10-K | 2026-03-05 | 2025-12-31 |
| Major company event | 8-K | 2026-03-05 | 2026-03-05 |
| SCHEDULE 13G/A | - | 2026-03-05 | - |
| SCHEDULE 13G/A | - | 2026-02-17 | - |
| SCHEDULE 13G/A | - | 2026-02-17 | - |
| Insider trade | 4 | 2026-02-04 | 2026-02-02 |
| Insider trade | 4 | 2026-02-04 | 2026-02-02 |
| Insider trade | 4 | 2026-02-04 | 2026-02-02 |
| Insider trade | 4 | 2026-02-04 | 2026-02-02 |
| Insider trade | 4 | 2026-02-04 | 2026-02-02 |
| Insider trade | 4 | 2026-02-03 | 2025-12-10 |
| SCHEDULE 13G/A | - | 2026-01-30 | - |
| SCHEDULE 13G | - | 2026-01-21 | - |
| SCHEDULE 13G/A | - | 2025-11-14 | - |
| Quarterly report | 10-Q | 2025-11-10 | 2025-09-30 |
| Major company event | 8-K | 2025-11-10 | 2025-11-10 |
| SCHEDULE 13G/A | - | 2025-11-05 | - |
| SCHEDULE 13G | - | 2025-10-30 | - |
| SCHEDULE 13G/A | - | 2025-10-17 | - |
| SCHEDULE 13G | - | 2025-10-15 | - |
| Major company event | 8-K | 2025-09-09 | 2025-09-09 |
| SCHEDULE 13G/A | - | 2025-08-14 | - |
| SCHEDULE 13G | - | 2025-08-13 | - |
| SCHEDULE 13D/A | - | 2025-08-13 | - |
| SCHEDULE 13G/A | - | 2025-08-13 | - |
| Quarterly report | 10-Q | 2025-08-11 | 2025-06-30 |
| Major company event | 8-K | 2025-08-11 | 2025-08-11 |
| Major company event | 8-K | 2025-07-21 | 2025-07-21 |
| Insider trade | 4 | 2025-07-15 | 2025-07-11 |
| Prospectus supplement | 424B5 | 2025-07-02 | - |
| Major company event | 8-K | 2025-07-02 | 2025-07-01 |
| Prospectus supplement | 424B5 | 2025-07-01 | - |
| Major company event | 8-K | 2025-06-23 | 2025-06-23 |
| Insider trade | 4 | 2025-06-20 | 2025-06-18 |
| Insider trade | 4 | 2025-06-20 | 2025-06-18 |
| Insider trade | 4 | 2025-06-20 | 2025-06-18 |
| Insider trade | 4 | 2025-06-20 | 2025-06-18 |
| Major company event | 8-K | 2025-06-20 | 2025-06-18 |
| SCHEDULE 13G | - | 2025-05-15 | - |
| Quarterly report | 10-Q | 2025-05-12 | 2025-03-31 |